BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 31445411)

  • 1. Cytotoxic CD4
    Sanchez-Martinez A; Perdomo-Celis F; Acevedo-Saenz L; Rugeles MT; Velilla PA
    J Clin Virol; 2019 Oct; 119():17-23. PubMed ID: 31445411
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cytotoxic CD4 T cells in viral hepatitis.
    Aslan N; Yurdaydin C; Wiegand J; Greten T; Ciner A; Meyer MF; Heiken H; Kuhlmann B; Kaiser T; Bozkaya H; Tillmann HL; Bozdayi AM; Manns MP; Wedemeyer H
    J Viral Hepat; 2006 Aug; 13(8):505-14. PubMed ID: 16901280
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Apoptosis of HIV-specific CD8+ T cells: an HIV evasion strategy.
    Petrovas C; Mueller YM; Katsikis PD
    Cell Death Differ; 2005 Aug; 12 Suppl 1():859-70. PubMed ID: 15818412
    [No Abstract]   [Full Text] [Related]  

  • 4. High avidity CD8+ T cells efficiently eliminate motile HIV-infected targets and execute a locally focused program of anti-viral function.
    Foley MH; Forcier T; McAndrew E; Gonzalez M; Chen H; Juelg B; Walker BD; Irvine DJ
    PLoS One; 2014; 9(2):e87873. PubMed ID: 24551068
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.
    Munier CML; van Bockel D; Bailey M; Ip S; Xu Y; Alcantara S; Liu SM; Denyer G; Kaplan W; ; Suzuki K; Croft N; Purcell A; Tscharke D; Cooper DA; Kent SJ; Zaunders JJ; Kelleher AD
    Vaccine; 2016 Oct; 34(44):5251-5261. PubMed ID: 27639281
    [TBL] [Abstract][Full Text] [Related]  

  • 6. HIV-Specific Granzyme B-Secreting but Not Gamma Interferon-Secreting T Cells Are Associated with Reduced Viral Reservoirs in Early HIV Infection.
    Yue FY; Cohen JC; Ho M; Rahman AKMN; Liu J; Mujib S; Saiyed A; Hundal S; Khozin A; Bonner P; Liu D; Benko E; Kovacs C; Ostrowski M
    J Virol; 2017 Apr; 91(8):. PubMed ID: 28179527
    [TBL] [Abstract][Full Text] [Related]  

  • 7. CD8+ T-cells: function and response to HIV infection.
    Gulzar N; Copeland KF
    Curr HIV Res; 2004 Jan; 2(1):23-37. PubMed ID: 15053338
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Maintenance of HIV-specific central and effector memory CD4 and CD8 T cells requires antigen persistence.
    Sester U; Sester M; Köhler H; Pees HW; Gärtner BC; Wain-Hobson S; Bocharov G; Meyerhans A
    AIDS Res Hum Retroviruses; 2007 Apr; 23(4):549-53. PubMed ID: 17451343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Delayed virus-specific CD8+ cytotoxic T lymphocyte activity in an HIV-infected individual with high CD4+ cell counts: correlations with various parameters of disease progression.
    Dalod M; Fiorentino S; Delamare C; Rouzioux C; Sicard D; Guillet JG; Gomard E
    AIDS Res Hum Retroviruses; 1996 Apr; 12(6):497-506. PubMed ID: 8679305
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Antigen-presenting T cells induce the development of cytotoxic CD4+ T cells. I. Involvement of the CD80-CD28 adhesion molecules.
    Mauri D; Wyss-Coray T; Gallati H; Pichler WJ
    J Immunol; 1995 Jul; 155(1):118-27. PubMed ID: 7541409
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effective Cytotoxic T Lymphocyte Targeting of Persistent HIV-1 during Antiretroviral Therapy Requires Priming of Naive CD8+ T Cells.
    Smith KN; Mailliard RB; Piazza PA; Fischer W; Korber BT; Fecek RJ; Ratner D; Gupta P; Mullins JI; Rinaldo CR
    mBio; 2016 May; 7(3):. PubMed ID: 27247230
    [TBL] [Abstract][Full Text] [Related]  

  • 12. CD25+ regulatory T cells isolated from HIV-infected individuals suppress the cytolytic and nonlytic antiviral activity of HIV-specific CD8+ T cells in vitro.
    Kinter AL; Horak R; Sion M; Riggin L; McNally J; Lin Y; Jackson R; O'shea A; Roby G; Kovacs C; Connors M; Migueles SA; Fauci AS
    AIDS Res Hum Retroviruses; 2007 Mar; 23(3):438-50. PubMed ID: 17411377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite Controllers.
    Phetsouphanh C; Aldridge D; Marchi E; Munier CML; Meyerowitz J; Murray L; Van Vuuren C; Goedhals D; Fidler S; Kelleher A; Klenerman P; Frater J
    Front Immunol; 2019; 10():1844. PubMed ID: 31440240
    [TBL] [Abstract][Full Text] [Related]  

  • 14. To kill or be killed: how HIV exhausts the immune system.
    Gougeon ML
    Cell Death Differ; 2005 Aug; 12 Suppl 1():845-54. PubMed ID: 15832178
    [No Abstract]   [Full Text] [Related]  

  • 15. Cytokines from vaccine-induced HIV-1 specific cytotoxic T lymphocytes: effects on viral replication.
    Bollinger RC; Quinn TC; Liu AY; Stanhope PE; Hammond SA; Viveen R; Clements ML; Siliciano RF
    AIDS Res Hum Retroviruses; 1993 Nov; 9(11):1067-77. PubMed ID: 7906131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. HIV-specific CD8+ T cell proliferation is coupled to perforin expression and is maintained in nonprogressors.
    Migueles SA; Laborico AC; Shupert WL; Sabbaghian MS; Rabin R; Hallahan CW; Van Baarle D; Kostense S; Miedema F; McLaughlin M; Ehler L; Metcalf J; Liu S; Connors M
    Nat Immunol; 2002 Nov; 3(11):1061-8. PubMed ID: 12368910
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Immunological benefits of antiretroviral therapy in very early stages of asymptomatic chronic HIV-1 infection.
    Plana M; García F; Gallart T; Tortajada C; Soriano A; Palou E; Maleno MJ; Barceló JJ; Vidal C; Cruceta A; Miró JM; Gatell JM
    AIDS; 2000 Sep; 14(13):1921-33. PubMed ID: 10997396
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Dysregulation of CD28 and CTLA-4 expression by CD4 T cells from previously immunodeficient HIV-infected patients with sustained virological responses to highly active antiretroviral therapy.
    Stone SF; Price P; French MA
    HIV Med; 2005 Jul; 6(4):278-83. PubMed ID: 16011533
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Frequency of cytokine-producing T cells in HIV-infected patients treated with stavudine, didanosine, and ritonavir.
    Levacher M; Bouscarat F; Landman R; Chau F; Damond F; Gaudebout C; Mathez D; Leibowitch J; Saimot AG; Sinet M
    AIDS Res Hum Retroviruses; 2000 Nov; 16(17):1869-75. PubMed ID: 11118072
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunization with an HIV-1 immunogen induces CD4+ and CD8+ HIV-1-specific polyfunctional responses in patients with chronic HIV-1 infection receiving antiretroviral therapy.
    Valor L; Navarro J; Carbone J; Rodríguez-Sáinz C; Gil J; López F; Fernández-Cruz E;
    Vaccine; 2008 May; 26(22):2738-45. PubMed ID: 18433946
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.